Association Between Academic Medical Center Pharmaceutical Detailing Policies and Physician Prescribing

• Published in: JAMA : the journal of the American Medical Association Vol. 317; no. 17; pp. 1785 - 1795
• Main Authors: Larkin, Ian, Ang, Desmond, Steinhart, Jonathan, Chao, Matthew, Patterson, Mark, Sah, Sunita, Wu, Tina, Schoenbaum, Michael, Hutchins, David, Brennan, Troyen, Loewenstein, George
• Format: Journal Article
• Language: English
• Published: United States American Medical Association 02.05.2017
• Subjects: Academic Medical Centers - statistics & numerical data; Anticholesteremic Agents - therapeutic use; Antidepressants; Antidepressive Agents - therapeutic use; Antihypertensive Agents - therapeutic use; Antihypertensives; Antipsychotic Agents - therapeutic use; Antipsychotics; Attention deficit hyperactivity disorder; California; Cardiovascular Agents - therapeutic use; Conflict of Interest; Conflicts of interest; Data processing; Diabetes; Diabetes mellitus; Drug development; Drug Industry; Drug Prescriptions - statistics & numerical data; Drugs; Exposure; Gastroesophageal reflux; Health care facilities; Health facilities; Humans; Hyperactivity; Hypnotics; Hypnotics and Sedatives - therapeutic use; Hypoglycemic Agents - therapeutic use; Illinois; Insomnia; Interprofessional Relations; Intervention; Market shares; Markets; Massachusetts; Medical personnel; New York; Organizational Policy; Original Investigation; Pennsylvania; Pharmaceutical industry; Pharmaceuticals; Physicians; Physicians - statistics & numerical data; Policy implementation; Prescription drugs; Prescription Drugs - therapeutic use; Prescriptions; Regression Analysis; Salespeople; Sleep; Sleep disorders

IMPORTANCE: In an effort to regulate physician conflicts of interest, some US academic medical centers (AMCs) enacted policies restricting pharmaceutical representative sales visits to physicians (known as detailing) between 2006 and 2012. Little is known about the effect of these policies on physic...